Literature DB >> 18186418

Knowledge of risk factors for falling reported by patients with Parkinson disease.

Cheryl A Sadowski1, C Allyson Jones, Beverly Gordon, David H Feeny.   

Abstract

This study examined awareness of the risk factors for falling among a group of community dwelling patients with Parkinson disease (PD) using the Falls Risk Awareness Questionnaire (FRAQ). A cross-sectional survey of 28 patients who attended a Movement Disorders Clinic for treatment of PD was used. FRAQ is a 28-item self-administered survey that assesses the knowledge and perception of risk factors for falling. Demographic, medical, and medication data were gathered from both the participants and clinic charts. Twenty-three (82%) of the participants reported falls in the past; seven (30%) had fallen within the past month. Nineteen (68%) of the participants felt they were at risk for further falls. When asked to list potential risk factors for falling, only 14% could identify medication as a risk factor. Persons with PD are at substantial risk of falling, yet many appear to be unaware of common risk factors, especially medication use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18186418     DOI: 10.1097/01376517-200712000-00004

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  2 in total

1.  Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson's disease.

Authors:  Joe R Nocera; Elizabeth L Stegemöller; Irene A Malaty; Michael S Okun; Michael Marsiske; Chris J Hass
Journal:  Arch Phys Med Rehabil       Date:  2013-03-06       Impact factor: 3.966

2.  Protocol for a home-based integrated physical therapy program to reduce falls and improve mobility in people with Parkinson's disease.

Authors:  Meg E Morris; Clarissa Martin; Jennifer L McGinley; Frances E Huxham; Hylton B Menz; Nicholas F Taylor; Mary Danoudis; Jennifer J Watts; Sze-Ee Soh; Andrew H Evans; Malcolm Horne; Peter Kempster
Journal:  BMC Neurol       Date:  2012-07-16       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.